Skip to main content
. 2014 Aug 6;33(1):66. doi: 10.1186/s13046-014-0066-9

Table 1.

Association between expression level of DPYSL3 mRNA and clinicopathological parameters in 238 patients

Variables High DPYSL3 mRNA in GC tissue (n) Low DPYSL3 mRNA in GC tissue (n) P -value
Age     0.793
< 65 year 51 49
≥ 65 year 68 70
Gender     0.453
Male 87 92
Female 32 27
Carcinoembryonic antigen (ng/ml)     0.415
≤ 5 93 98
> 5 26 21
Carbohydrate antigen 19–9 (IU/ml)     0.504
≤ 37 95 99
> 37 24 20
Tumor location     0.769
Entire 12 8
Upper third 24 27
Middle third 37 35
Lower third 46 49
Tumor size (mm)     0.090
< 50 48 61
≥ 50 71 58
Tumor depth (UICC)     <0.001*
pT1-3 51 77
pT4 68 42
Histology     0.098
Papillary 1 1
Well differentiated 4 10
Moderately differentiated 33 48
Poorly differentiated 74 56
Signet ring cell 5 2
Mucinous 2 2
Differentiation     0.006*
Differentiated 39 60
Undifferentiated 80 59
Lymphatic involvement     0.016*
Absent 11 24
Present 108 95
Vessel invasion     0.036*
Absent 44 60
Present 75 59
Infiltrative growth type     <0.001*
Invasive growth 55 28
Expansive growth 64 90
Lymph node metastasis     <0.001*
Absent 32 57
Present 87 62
Peritoneal lavage cytology     0.001*
Negative 84 104
Positive 35 15
UICC stage     0.032*
I - III 77 92
IV 42 27

Abbreviations: UICC Union for International Cancer Control. *Statistically significant (P < 0.05).